- UT Medicine launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Fitness wearable Whoop rolls out virtual clinician visits, EHR integration
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- New Jersey system, university create college of community health
- 3 PDS Health headlines to know in 1 week
- 67 health systems ranked by net income
- 46 recent hospital, health system executive moves
- Remarks at the Conference on Financial Market Regulation
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- Georgia mental health provider adds after-hours outpatient program
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- Real estate platform acquires Florida MOB for $28.5M
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Missouri system expands interventional cardiology services
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- 5 DSOs making headlines
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- Exposure Therapy Can Successfully Ease Peanut Allergies
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Revisiting Pharma’s tariff reality
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- AbbVie’s Skyrizi beats out J&J’s Tremfya in in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
President Trump signed an executive order yesterday directing the federal government to promote addiction recovery:
ADDRESSING ADDICTION THROUGH THE GREAT AMERICAN RECOVERY INITIATIVE
Executive Orders
January 29, 2026By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered:
Section 1. Purpose and Policy. The disease of addiction, also known as substance use disorder, is a crisis that touches families in every community and neighborhood in our Nation. 48.4 million Americans, or 16.8 percent of our Nation’s population, suffer from addiction, and my Administration will continue to respond to a crisis of this scale with the attention it deserves. Over the past year, we have made incredible progress in stopping the inflow of illegal drugs that threaten American communities. We must now supplement that work by furthering a national effort to prioritize addiction treatment and recovery.
Addiction is a chronic, treatable disease with relapse rates similar to other chronic diseases. Unfortunately, very few Americans who need treatment ever receive it or believe they need it. Among the 40.7 million adults who had a substance use disorder in 2024 and did not receive substance use treatment, 95.6 percent (or 38.1 million people) did not perceive that they needed treatment. Despite significant investment of resources, addiction recovery efforts remain fragmented and do not keep pace with scientific advancements.
The costs of these failures are devastating, not only in lives lost, but also in the ripple effects across our economy, workforce, and national strength. Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability, and lost productivity that together cost the United States hundreds of billions of dollars each year.
The framework for addiction treatment should parallel that of other chronic diseases — utilizing evidence-based care, scientific advancement, continuous support, and community connection. My Administration will drive a new national response to the disease of addiction that will create stronger coordination across government, the healthcare sector, faith communities, and the private sector in order to save lives, restore families, strengthen our communities, and build the Great American Recovery.
Section 2. Launching the Great American Recovery Initiative. (a) There is hereby established the White House Great American Recovery Initiative (Initiative) co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery. There shall be an Executive Director who shall administer and execute the day to day operations of the Initiative, and who shall report to the Assistant to the President for Domestic Policy.
(b) In addition to the Co-Chairs and the Executive Director, the Initiative shall consist of the following officials, or their designees:
(i) the Attorney General;
(ii) the Secretary of the Interior;
(iii) the Secretary of Education;
(iv) the Secretary of Labor;
(v) the Secretary of Housing and Urban Development;
(vi) the Secretary of Veterans Affairs;
(vii) the Assistant to the President and Chief of Staff;
(viii) the Assistant to the President and Special Envoy for Peace Missions;
(ix) the Assistant to the President and Cabinet Secretary;
(x) the Director of National Drug Control Policy;
(xi) the Administrator of the Centers for Medicare and Medicaid Services;
(xii) the Commissioner of Food and Drugs;
(xiii) the Director of the National Institutes of Health;
(xiv) the Assistant Secretary for Mental Health and Substance Use, Department of Health and Human Services; and
(xv) the heads of such other executive departments, agencies, and offices that the Co-Chairs and the Executive Director may from time to time designate or invite to participate.
(c) The Co-Chairs may hold public hearings, meetings, roundtables, and similar events, as appropriate, and may receive expert input from leaders in public health, addiction and recovery treatment, and other relevant subject matter areas.
Section 3. Addressing the Disease of Addiction. The Co-Chairs and the Executive Director, along with the other members of the Initiative, shall:
(i) recommend all necessary steps to coordinate the Federal Government’s response to the addiction crisis, including by better aligning relevant Federal programs, setting clear objectives, and providing data-driven updates to the public on progress towards meeting these objectives;
(ii) take appropriate actions to increase awareness of the disease of addiction, help Americans receive the treatment they need, and foster a culture that celebrates recovery;
(iii) advise heads of executive departments and agencies (agency heads) on how to implement programs that integrate prevention, early intervention, treatment, recovery support, and re-entry into all relevant public health, healthcare, criminal justice, workforce, education, housing and social services systems, and remove outdated silos between agencies, programs, or systems, in each case as deemed appropriate by the agency head and consistent with applicable law;
(iv) advise agency heads on directing appropriate grants to support addiction recovery, with a focus on prevention, treatment, and long-term resilience; and
(v) consult with States, tribal nations, local jurisdictions, community-based organizations, faith‑based organizations, the private sector, and philanthropic entities on the best strategies to ensure more Americans receive the treatment they need and celebrate individuals going through the recovery process.
Section 4. General Provisions. (a) Nothing in this order shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with applicable law and subject to the availability of appropriations.
(c) This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.
(d) The costs for publication of this order shall be borne by the Department of Health and Human Services.
DONALD J. TRUMP
THE WHITE HOUSE,
January 29, 2026.
The White House Fact Sheet:
Fact Sheet: President Donald J. Trump Launches the Great American Recovery Initiative to Address the Addiction Crisis
The White House
January 29, 2026LAUNCHING THE GREAT AMERICAN RECOVERY INITIATIVE: Today, President Donald J. Trump signed an Executive Order creating the White House Great American Recovery Initiative to coordinate a national response to the disease of addiction across government, healthcare, faith communities, and the private sector in order to save lives, restore families, strengthen our communities, and build the Great American Recovery.
The Order establishes the Initiative, co-chaired by the Secretary of Health and Human Services and the Senior Advisor for Addiction Recovery.
- Additional members of the Initiative include an executive director, cabinet secretaries, and senior administration leaders, some with deeply personal ties to the addiction crisis who are committed to ensuring Americans get the help they need.
The Order directs the Initiative to:
- Recommend all necessary steps to coordinate the Federal Government’s response to the addiction crisis, including by better aligning relevant Federal programs, setting clear objectives, and providing data-driven updates to the public on progress towards meeting these objectives;
- Take appropriate actions to increase awareness of the disease of addiction, help Americans receive the treatment they need, and foster a culture that celebrates recovery;
- Advise agencies on how to implement programs that integrate prevention, early intervention, treatment, recovery support, and re-entry;
- Advise agencies on directing appropriate grants to support addiction recovery, with a focus on prevention, treatment, and long-term resilience; and
- Consult with States, tribal nations, local jurisdictions, community-based organizations, faith-based organizations, the private sector, and philanthropic entities on the best strategies to ensure more Americans receive the treatment they need and celebrate individuals going through the recovery process.
MAKING PROGRESS ON THE DISEASE OF ADDICTION: The disease of addiction, also known as substance use disorder, is a crisis that touches families in every community in our Nation.
- Addiction is a chronic, treatable disease with relapse rates similar to other chronic diseases.
- 48.4 million Americans, or 16.8% of our Nation’s population, suffer from addiction, yet very few who need treatment receive it or believe they need it.
- Among the 40.7 million adults with a substance use disorder in 2024 who did not receive treatment, 95.6% (or 38.1 million people) did not perceive they needed it.
- Addiction contributes to declining workforce participation, increased healthcare costs, homelessness, family instability, and lost productivity that together cost the United States hundreds of billions of dollars each year.
- The framework for addiction treatment should parallel that of other chronic diseases – utilizing evidence-based care, scientific advancement, continuous support, and community connection.
DELIVERING ON PROMISES TO ADDRESS THE ADDICTION CRISIS: President Trump is committed to ending the addiction crisis and ensuring every American can access the help they need.
- He signed the SUPPORT Patients and Communities Reauthorization Act of 2025, strengthening Federal programs that address substance use disorders, overdoses, and mental health.
- He has taken aggressive action to stop the flow of deadly drugs into the United States, determined to save lives from the devastation caused by illicit narcotics crossing the border.
- He signed into law the HALT Fentanyl Act to permanently place Fentanyl-related substances into Schedule I of the Controlled Substances Act.
- His Administration is working to prevent drug use before it starts, strengthen treatment that leads to long-term recovery, and advance research and data to support effective drug control strategies.
- These efforts build on historic actions from President Trump’s first term, when he:
- Declared the opioid crisis a nationwide public health emergency.
- Signed the SUPPORT for Patients and Communities Act, the largest-ever legislative effort to address a drug crisis in our Nation’s history.
- Launched the Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand in order to confront the many causes fueling the drug crisis.
- Signed the CRIB Act, allowing Medicaid to help mothers and their babies who are born physically dependent on opioids by covering their care in residential pediatric recovery facilities.
- Distributed $1 billion in grants for addiction prevention and treatment.
- Announced a Safer Prescriber Plan to decrease the number of opioid prescriptions filled.
- Expanded access to medication-assisted treatment and life-saving Naloxone.
- Launched FindTreatment.gov, a tool to find help for substance abuse.
- Approved 29 state Medicaid demonstrations to improve access to opioid use disorder treatment, including new flexibility to cover inpatient and residential treatment.
The $ 100 million HHS pilot program:
Secretary Kennedy Announces $100 Million Investment in Great American Recovery
FOR IMMEDIATE RELEASE February 2, 2026
HHS Press Office
202-690-6343OXON HILL, MARYLAND — FEBRUARY 2, 2026 — Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. today announced a comprehensive plan to strengthen prevention, expand treatment, and carry out the executive order President Trump signed last week to ignite the Great American Recovery. The centerpiece of this plan is a $100 million investment to solve long-standing homelessness issues, fight opioid addiction, and improve public safety by expanding treatment that emphasizes recovery and self-sufficiency.
The Safety Through Recovery, Engagement, and Evidence-based Treatment and Supports — or STREETS — Initiative will fund targeted outreach, psychiatric care, medical stabilization and crisis intervention, while connecting Americans experiencing homelessness and addiction to stable housing with a clear focus on long-term recovery and independence.
“Addiction begins in isolation and ends in reconnection,” said Secretary Kennedy, who is co-chair of President Trump’s Great American Recovery Initiative. “Thanks to the leadership of President Trump, we are bringing Americans suffering from addiction out of the shadows and back into community.
”Secretary Kennedy made the announcement at Prevention Day, the largest government-sponsored gathering dedicated to advancing the prevention of substance use, hosted by the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of HHS.
The $100 million investment directed by Secretary Kennedy is a clear departure from Biden-era policies that were misguided, failing to stem the tide of death, addiction, homelessness, and crime in American communities. These policies focused not on preventing and treating individuals, but rather non-effective interventions such as harm reduction, supporting housing first, and other strategies that enabled future drug use — and were never intended to support people in their recovery to lead productive lives in their communities.
Substance use disorder — impairment caused by repeated use of alcohol or other drugs — among people ages 12 and older rose from 7.4% in 2019 to 16.8% in 2024, according to SAMHSA survey data. Nearly 8 in 10 people with a substance use disorder in 2024 did not receive treatment.
Secretary Kennedy also announced the $10 million Assisted Outpatient Treatment (AOT) grant program to support adults with serious mental illness. AOT is a civil court-ordered, community-based outpatient mental health treatment program for adults with serious mental illness who are unable to engage with conventional outpatient treatment and are unlikely to be able to live safely in their community. The program is designed to work within the civil court system that supports engagement with community-based treatment as an alternative to more costly restrictive levels of care, homelessness, and interactions with the criminal justice system.
President Trump’s Executive Order Ending Crime and Disorder on America’s Streets on July 24, 2025 directed SAMHSA grants toward evidence-based substance use disorder programs with proven results and assisted outpatient treatment that moves people with serious mental illness or addiction off the streets and into stable housing and support networks. SAMHSA in September 2025 awarded more than $45 million in new supplemental funding to State Opioid Response program recipients to focus on sober or recovery housing among young adults.
The STREETS Initiative and AOT grant announcements coincide with SAMHSA’s $794 million first allocation of 2026 annual block grant awards, with $319 million going to support comprehensive community mental health services for adults with serious mental illness and children with serious emotional disturbance, and $475 million to the agency’s Substance Use Prevention, Treatment, and Recovery Services Block Grant program to prevent and treat substance abuse.
To help prevent family breakdown from substance use disorder, HHS’ Administration for Children and Families today under Secretary Kennedy’s plan added three Medications for Opioid Use Disorder (MOUD) as prevention services eligible for federal funding. States and tribes can now receive a 50% federal match, respectively, to provide buprenorphine, methadone, and naltrexone to parents when children are at imminent risk of entering foster care but can remain safely in the home or in a kinship placement with access to these treatments.
All three MOUD are U.S. Food and Drug Administration-approved, well-established, evidence-based tools that support recovery, promote family stability, and reduce risk factors associated with child welfare involvement.
SAMHSA and ACF intend to issue a Dear Colleague letter to emphasize that both agencies welcome full participation from faith-based organizations in their programs and activities.
President Trump declared upon establishing the White House Faith Office on February 7, 2025, “The executive branch wants faith-based entities, community organizations, and houses of worship, to the fullest extent permitted by law, to compete on a level playing field for grants, contracts, programs, and other Federal funding opportunities.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














